222 related articles for article (PubMed ID: 31754018)
21. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
22. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
24. Lipocalin 2 Influences Bone and Muscle Phenotype in the
Ponzetti M; Ucci A; Maurizi A; Giacchi L; Teti A; Rucci N
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055145
[TBL] [Abstract][Full Text] [Related]
25. Growth Hormone Increases Bone Toughness and Decreases Muscle Inflammation in Glucocorticoid-Treated Mdx Mice, Model of Duchenne Muscular Dystrophy.
Yoon SH; Grynpas MD; Mitchell J
J Bone Miner Res; 2019 Aug; 34(8):1473-1486. PubMed ID: 31188496
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
27. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
[TBL] [Abstract][Full Text] [Related]
28. Serum Antibodies to N-Glycolylneuraminic Acid Are Elevated in Duchenne Muscular Dystrophy and Correlate with Increased Disease Pathology in Cmah
Martin PT; Kawanishi K; Ashbrook A; Golden B; Samraj A; Crowe KE; Zygmunt DA; Okerblom J; Yu H; Maki A; Diaz S; Chen X; Janssen PML; Varki A
Am J Pathol; 2021 Aug; 191(8):1474-1486. PubMed ID: 34294193
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy.
Gordon BS; Delgado Díaz DC; Kostek MC
Clin Nutr; 2013 Feb; 32(1):104-11. PubMed ID: 22795790
[TBL] [Abstract][Full Text] [Related]
30. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
31. Cathelicidin-related antimicrobial peptide mediates skeletal muscle degeneration caused by injury and Duchenne muscular dystrophy in mice.
Choi MC; Jo J; Lee M; Park J; Yao TP; Park Y
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3091-3105. PubMed ID: 36059045
[TBL] [Abstract][Full Text] [Related]
32. Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice.
Li H; Sun H; Qian B; Feng W; Carney D; Miller J; Hogan MV; Wang L
J Bone Miner Res; 2020 Apr; 35(4):738-752. PubMed ID: 31800971
[TBL] [Abstract][Full Text] [Related]
33. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
34. PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD).
Sengupta K; Loro E; Khurana TS
Sci Rep; 2020 Dec; 10(1):21492. PubMed ID: 33298994
[TBL] [Abstract][Full Text] [Related]
35. Black bear parathyroid hormone has greater anabolic effects on trabecular bone in dystrophin-deficient mice than in wild type mice.
Gray SK; McGee-Lawrence ME; Sanders JL; Condon KW; Tsai CJ; Donahue SW
Bone; 2012 Sep; 51(3):578-85. PubMed ID: 22584007
[TBL] [Abstract][Full Text] [Related]
36. Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.
Albuquerque-Pontes GM; Casalechi HL; Tomazoni SS; Serra AJ; Ferreira CSB; Brito RBO; de Melo BL; Vanin AA; Monteiro KKDS; Dellê H; Frigo L; Marcos RL; de Carvalho PTC; Leal-Junior ECP
Lasers Med Sci; 2018 May; 33(4):755-764. PubMed ID: 29209866
[TBL] [Abstract][Full Text] [Related]
37. Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy.
Guerron AD; Rawat R; Sali A; Spurney CF; Pistilli E; Cha HJ; Pandey GS; Gernapudi R; Francia D; Farajian V; Escolar DM; Bossi L; Becker M; Zerr P; de la Porte S; Gordish-Dressman H; Partridge T; Hoffman EP; Nagaraju K
PLoS One; 2010 Jun; 5(6):e11220. PubMed ID: 20574530
[TBL] [Abstract][Full Text] [Related]
38. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
39. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
[TBL] [Abstract][Full Text] [Related]
40. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
